This article comprises a summary of scientific sessions on β-thalassaemia that took place on 2nd–4th February 2017, as part of the European Hematology Association Scientific Working Group meeting: Anaemias: Diagnosis and Treatment in the Omics Era, in Barcelona, Spain
In this issue
Rate this content's potential impact on patient outcomes
Thank you!
Please share some more information on the rating you have given